DermEdge Research

Mississauga L5H 1G9

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Eczema, Psoriasis

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed